Relay Therapeutics, Inc. - RLAY
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 09, 2026 | Chief Financial Officer | M | D | 1,800.0 | 0.0 | 0.0 | 61,563.0 | View | |
| Apr 09, 2026 | Chief Financial Officer | S | D | 1,800.0 | 15.0 | 27,000.0 | 213,867.0 | View | |
| Apr 09, 2026 | Chief Financial Officer | M | A | 1,800.0 | 5.22 | 9,396.0 | 215,667.0 | View | |
| Apr 09, 2026 | Chief Financial Officer | S | D | 17,717.0 | 13.01 | 230,498.17 | 213,867.0 | View | |
| Mar 11, 2026 | Chief Financial Officer | S | D | 17,717.0 | 10.06 | 178,233.02 | 231,584.0 | View | |
| Jan 29, 2026 | See remarks | S | D | 1,354.0 | 8.45 | 11,441.3 | 276,610.0 | View | |
| Jan 29, 2026 | See remarks | S | D | 11,684.0 | 7.62 | 89,032.08 | 277,964.0 | View | |
| Jan 29, 2026 | See remarks | A | A | 994.0 | 2.99 | 2,972.06 | 338,463.0 | View | |
| Jan 29, 2026 | President, R&D | S | D | 2,686.0 | 8.45 | 22,696.7 | 420,047.0 | View | |
| Jan 29, 2026 | President, R&D | S | D | 18,895.0 | 7.62 | 143,979.9 | 422,733.0 | View | |
| Jan 29, 2026 | Chief Financial Officer | S | D | 1,695.0 | 8.45 | 14,322.75 | 249,301.0 | View | |
| Jan 29, 2026 | Chief Financial Officer | S | D | 13,820.0 | 7.62 | 105,308.4 | 250,996.0 | View | |
| Jan 15, 2026 | Chief Financial Officer | A | A | 400,000.0 | 0.0 | 0.0 | 400,000.0 | View | |
| Jan 15, 2026 | President, R&D | A | A | 575,000.0 | 0.0 | 0.0 | 575,000.0 | View | |
| Jan 15, 2026 | See remarks | A | A | 475,000.0 | 0.0 | 0.0 | 475,000.0 | View | |
| Jan 15, 2026 | President and CEO | A | A | 1,450,000.0 | 0.0 | 0.0 | 1,450,000.0 | View | |
| Jan 07, 2026 | President and CEO | S | D | 43,168.0 | 7.82 | 337,573.76 | 661,041.0 | View | |
| Jan 07, 2026 | President and CEO | A | A | 994.0 | 2.99 | 2,972.06 | 704,209.0 | View | |
| Nov 06, 2025 | — | A | A | 207,931.0 | 0.0 | 0.0 | 207,931.0 | View | |
| Nov 06, 2025 | — | A | A | 207,931.0 | 0.0 | 0.0 | 207,931.0 | View | |
| Nov 04, 2025 | President and CEO | S | D | 62,073.0 | 7.0 | 434,511.0 | 703,215.0 | View | |
| Oct 30, 2025 | Chief Financial Officer | S | D | 21,664.0 | 7.29 | 157,930.56 | 313,631.0 | View | |
| Oct 30, 2025 | See remarks | S | D | 21,394.0 | 7.5 | 160,455.0 | 337,469.0 | View | |
| Oct 30, 2025 | See remarks | S | D | 19,135.0 | 7.29 | 139,494.15 | 358,863.0 | View | |
| Oct 30, 2025 | President, R&D | S | D | 30,897.0 | 7.29 | 225,239.13 | 521,823.0 | View |